SCHEMBL28485488

SCHEMBL28485488

CS(=O)(=O)OCCN(CCOS(C)(=O)=O)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCN(OS(C)(=O)=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 7/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HPGD P15428 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
LMNA P02545 1/20 0.41
CYP2C9 P11712 1/20 0.40
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21410445 0.90 ALDH1A1 (0.53) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245063 0.89 ALDH1A1 (0.50) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL21410438 0.88 MAPT (0.51) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245077 0.88 L3MBTL1 (0.44) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245047 0.88 MAPT (0.48) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL28480820 0.88 L3MBTL1 (0.42) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245121 0.87 HTT (0.53) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245072 0.87 L3MBTL1 (0.45) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL21410815 0.87 ALDH1A1 (0.52) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL23245059 0.87 L3MBTL1 (0.43) L3MBTL1ALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111918864-A Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders 阿基利斯医疗有限公司 2020-11-10 CN claimed